Jubilant Pharmova Limited has informed the Exchange regarding Resignation of Dr. Ramakrishnan Arul as Executive Director of the company w.e.f. August 31, 2025.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Smallcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova Limited has informed the stock exchange about the resignation of Dr. Ramakrishnan Arul from the position of Executive Director of the company. The resignation will take effect from August 31, 2025. No reasons for the resignation or succession plans have been disclosed in this filing. Dr. Arul had been serving as a member of the company's board as an Executive Director, which is a Key Managerial Personnel (KMP) role under Indian company law. Investors may want to watch for further filings clarifying the circumstances and any replacement appointment.
The exit of an Executive Director may signal a leadership change at the board level. Shareholders should monitor for any follow-up announcements regarding the reason for the resignation or a replacement, as this could affect management continuity and investor sentiment.